中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共28条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 18
作者:  Li, Ning;  Zhu, Jianqing;  Yin, Rutie;  Wang, Jing;  Pan, Lingya;  Kong, Beihua;  Zheng, Hong;  Liu, Jihong;  Wu, Xiaohua;  Wang, Li;  Huang, Yi;  Wang, Ke;  Zou, Dongling;  Zhao, Hongqin;  Wang, Chunyan;  Lu, Weiguo;  Lin, An;  Lou, Ge;  Li, Guiling;  Qu, Pengpeng;  Yang, Hongying;  Zhen, Xiaoa;  Hang, Wenzhao;  Hou, Jianmei;  Banerjee, Ashish;  Wu, Lingying
收藏  |  浏览/下载：36/0  |  提交时间：2022/12/23
Drug-resistant HER2-positive breast cancer: Molecular mechanisms and overcoming strategies 期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:  Wu, Xiaofan;  Yang, Hongjian;  Yu, Xingfei;  Qin, Jiang-Jiang
收藏  |  浏览/下载：50/0  |  提交时间：2022/12/22
HER2  breast cancer  targeted therapy  drug resistance  overcoming strategies  
Sugemalimab vs Placebo after cCRT or sCRT in pts with Unresectable Stage III NSCLC: Final PFS Analysis of a Phase 3 Study 期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2022, 卷号: 17
作者:  Wu, Y. -L.;  Zhou, Q.;  Chen, M.;  Pan, Y.;  Jian, O.;  Hu, D.;  Lin, Q.;  Wu, G.;  Cui, J.;  Chang, J.;  Cheng, Y.;  Huang, C.;  Liu, A.;  Yang, N.;  Gong, Y.;  Zhu, C.;  Ma, Z.;  Fang, J.;  Chen, G.;  Zhao, J.;  Shi, A.;  Lin, Y.;  Li, G.;  Liu, Y.;  Wang, D.;  Wu, R.;  Xu, X.;  Shi, J.;  Liu, Z.;  Wang, J.;  Yang, J.
收藏  |  浏览/下载：33/0  |  提交时间：2022/12/23
CCRT  sCRT  PD-L1 inhibitor  
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Lou, Ge;  An, Ruifang;  Zhang, Guonan;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Zheng, Hong;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Hao, Min;  Huang, Yi;  Lin, Zhongqiu;  Wang, Dong;  Guo, Xiaoqing;  Yao, Shuzhong;  Wan, Xiaoyun;  Zhou, Huaijun;  Yao, Liangqing;  Yang, Xielan;  Cui, Heng;  Meng, Yuanguang;  Zhang, Songling;  Qu, Jing;  Zhang, Ben;  Zou, Jianjun;  Wu, Lingying
收藏  |  浏览/下载：32/0  |  提交时间：2022/12/22
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Sun, Yan;  Hu, Chaosu;  Lin, Qin;  Gao, Li;  Wang, Jianhua;  Zhu, Xiaodong;  Hao, Junfang;  Lang, Jin Yi;  Wang, Peiguo;  Ye, Ming;  Li, Xia;  Xu, Benhua;  Wu, Rong;  Bai, Chunmei;  You, Qingshan;  Chen, Xiaozhong;  Wang, Jun;  Hu, Desheng;  Wu, Gang;  Pan, Jian-Ji
收藏  |  浏览/下载：31/0  |  提交时间：2022/12/23
Olaparib maintenance monotherapy in Chinese patients with platinum-sensitive relapsed ovarian cancer: China cohort from the phase III SOLO2 trial 期刊论文
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022
作者:  Liu, Jihong;  Yin, Rutie;  Wu, Lingying;  Zhu, Jianqing;  Lou, Ge;  Wu, Xiaohua;  Zhou, Qi;  Gao, Yunong;  Kong, Beihua;  Lu, Xin;  Wang, Jing;  Chen, Youguo;  Cheng, Ying;  Wang, Yueling;  Lu, Weiguo;  Li, Wei;  Ma, Xin;  Hsu, Kate
收藏  |  浏览/下载：55/0  |  提交时间：2022/05/05
BRCA mutation  China  olaparib  ovarian cancer  PARP inhibitor  
Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial 期刊论文
LANCET ONCOLOGY, 2022, 卷号: 23
作者:  Zhou, Qing;  Chen, Ming;  Jiang, Ou;  Pan, Yi;  Hu, Desheng;  Lin, Qin;  Wu, Gang;  Cui, Jiuwei;  Chang, Jianhua;  Cheng, Yufeng;  Huang, Cheng;  Liu, Anwen;  Yang, Nong;  Gong, Youling;  Zhu, Chuan;  Ma, Zhiyong;  Fang, Jian;  Chen, Gongyan;  Zhao, Jun;  Shi, Anhui;  Lin, Yingcheng;  Li, Guanghui;  Liu, Yunpeng;  Wang, Dong;  Wu, Rong;  Xu, Xinhua;  Shi, Jianhua;  Liu, Zhihua;  Cui, Na;  Wang, Jingru;  Wang, Qiang;  Zhang, Ran;  Yang, Jason;  Wu, Yi-Long
收藏  |  浏览/下载：75/0  |  提交时间：2022/03/21
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine-Refractory Differentiated Thyroid Cancer The REALITY Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2021
作者:  Lin, Yansong;  Qin, Shukui;  Li, Zhiyong;  Yang, Hui;  Fu, Wei;  Li, Shaohua;  Chen, Wenxin;  Gao, Zairong;  Miao, Weibing;  Xu, Huiqin;  Zhang, Qing;  Zhao, Xinming;  Bao, Jiandong;  Li, Linfa;  Ren, Yuan;  Lin, Chenghe;  Jing, Shanghua;  Ma, Qingjie;  Liang, Jun;  Chen, Guang;  Zhang, Hong;  Zhang, Yifan;  Zhou, Xianfeng;  Sang, Yaxiong;  Hou, Zhiguo
收藏  |  浏览/下载：41/0  |  提交时间：2022/01/25
The Effect of Preoperative Methylprednisolone on Postoperative Delirium in Older Patients Undergoing Gastrointestinal Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial 期刊论文
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021
作者:  Xiang, Xiao-bing;  Chen, Hao;  Wu, Ying-li;  Wang, Ke;  Yue, Xiang;  Cheng, Xin-qi
收藏  |  浏览/下载：63/0  |  提交时间：2022/03/21
Brain-derived neurotrophic factor  Delirium  Heparan sulfate  Methylprednisolone  Syndecan-1  Tumor necrosis factor-alpha  
Fuzuloparib maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer: a multicenter, randomized, double-blind, placebo-controlled, phase III trial 期刊论文
GYNECOLOGIC ONCOLOGY, 2021, 卷号: 162
作者:  Li, Ning;  Zhang, Youzhong;  Wang, Jing;  Zhu, Jianqing;  Wang, Li;  Wu, Xiaohua;  Yao, Desheng;  Wu, Qiang;  Liu, Jihong;  Tang, Junying;  Yin, Rutie;  Zhang, Guonan;  Lou, Ge;  An, Ruifang;  Xia, Xiaoping;  Li, Qingshui;  Zhu, Yaping;  Hong, Zheng;  Yang, Xinfeng;  Hu, Yuanjing;  Zhang, Xin;  Wan, Xiaoyun;  Qu, Jing;  Zhang, Ben;  Wu, Lingying
收藏  |  浏览/下载：62/0  |  提交时间：2021/11/01